Bobyock E, Chernick W S
Hahnemann University School of Medicine, Department of Pharmacology, Philadelphia, Pennsylvania 19102.
J Dent Res. 1989 Nov;68(11):1489-94. doi: 10.1177/00220345890680110401.
Secretory dose-response curves were obtained with both acetylcholine and phenylephrine treatment in rat parotid and submandibular glands. Vasoactive intestinal peptide (VIP), which produced relatively low volumes of protein-rich saliva in rat salivary glands, also enhanced acetylcholine-, phenylephrine-, and substance-P-mediated fluid and protein secretion when administered in combination with these agents. The specific mechanisms involved in the synergistic actions of VIP with substances such as acetylcholine, phenylephrine, and substance P, which are primarily linked to the production of fluid secretion in rat salivary glands, have yet to be determined.
在大鼠腮腺和颌下腺中,通过乙酰胆碱和去氧肾上腺素处理获得了分泌剂量反应曲线。血管活性肠肽(VIP)在大鼠唾液腺中产生相对少量的富含蛋白质的唾液,当与这些药物联合给药时,它也增强了乙酰胆碱、去氧肾上腺素和P物质介导的液体和蛋白质分泌。VIP与乙酰胆碱、去氧肾上腺素和P物质等物质协同作用的具体机制尚未确定,这些物质主要与大鼠唾液腺中液体分泌的产生有关。